1. Myers RH, Kiely DK, Cupples LA, Kannel WB (1990) Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J 120:963–969.
2. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041–1046.
5. Kessler T, Vilne B, Schunkert H (2016) The impact of genome- wide association studies on the pathophysiology and therapy of cardiovascular disease. EMBO Mol Med 8:688–701
6. Samani NJ, Erdmann J, Hall AS, Hengstenberg C et al (2007) WTCCC, Cardiogenics. Genomewide association analysis of coronary artery disease. N Engl J Med 357:443–453
8. Schunkert H, Konig IR, Kathiresan S et al (2011). Large-scale association analysis identi es 13 new susceptibility loci for coronary artery disease. Nat Genet 43:333–338.
9.
9. Nelson CP, Goel A, Butterworth AS et al (2017) Association analyses based on false discovery rate implicate new loci for coronary artery disease. Nat Genet 49:1385–1391.
10. Van der Harst P, Verweij N (2018) The identication of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res 122:433–443.
11. Erdmann J, Kessler T, Munoz Venegas L, Schunkert H (2018). A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc Res. https://doi. org/10.1093/cvr/ cvy084.
12. Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA, Yang J (2017) 10 years of GWAS discovery: biology, func- tion, and translation. Am J Hum Genet 101(1):5–22.
13. Stitziel NO, Stirrups KE, Masca NG et al (2016) Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N Engl J Med 374:1134–1144.
14. Webb TR, Erdmann J, Stirrups KE et al (2017) Systematic evaluation of pleiotropyidenties 6 further loci associated with coronary artery disease. J Am Coll Cardiol 69:823–836
16. Braenne I, Kleinecke M, Reiz B et al (2016) Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction. Eur J Hum Genet 24:191–197
17. Stranneheim H, Wedell A (2016) Exome and genome sequenc- ing: a revolution for the discovery and diagnosis of monogenic disorders. J Intern Med 279(1):3–15
18. Trương Thanh Hương và cs. Phát hiện đột biến gen Fibrinogen beta (FGB) ở một bệnh nhân nhồi máu cơ tim có cơ địa dễ hình thành huyết khối, Y học Việt Nam, 1/2013, tr. 58.
19.
19. Trương Thanh Hương, Dương Đức Hùng, Nguyễn Thị Mai Ngọc, Lương Thị Lan Anh, Nguyễn Thị Trang. Phát hiện đột biến gen tổng hợp chuỗi nặng beta-myosin (YH7) trong bệnh cơ tim phì đại. Tạp chí Tim mạch học Việt Nam, số 65/2014
20.
20. Gerald F Watts, Phillip YA Ding, Thanh Huong Truong et al. Translational Research for Improving the Care of Familial Hypercholesterolemia: The “Ten Countries Study” and Beyond. J Atheroscler Thromb, 2016; 23: 891-900. doi: 10.5551/jat.35949.
21.
21. Kim Ngọc Thanh, Trần Trung Thành, Trần Đức Huy, Lê Hồng An, Trương Thanh Hương. Nghiên cứu bước đầu về tình trạng bệnh tăng Cholesterol máu có tính chất gia đình ở các trường hợp mắc bệnh ĐMV. Tạp chí tim mạch học Việt Nam – số 81.2018
22. Nguyễn Thị Thúy Mậu, Vũ Ngọc Trung, Nguyễn Hữu Hiếu, Nguyễn Thanh Thúy, Vũ Thị Thơm, Đinh Đoàn Long, Trịnh Hoàng Hà. Bước đầu đánh giá mối liên quan giữa đa hình gen CYP2C19 và độ ngưng tập tiểu cầu trên bệnh nhân nhồi máu cơ tim cấp tại một số bệnh viện ở Hà Nội. Tạp chí Khoa học ĐHQGHN: Khoa học Y Dược, Tập 33, Số 2 (2017) 68-74
23.
23. Khera AV, Won HH, Peloso GM, et al (2017) Association of rare and common variation in the
24.
lipoprotein lipase gene with coronary artery disease. JAMA 7(9):937–946 317.
25.
24. Ukraintseva S, Yashin A, Arbeev K, Kulminski A, Akushevich I, Wu D, Joshi G, Land KC, Stallard E (2016) Puzzling role of genetic risk factors in human longevity: “risk alleles” as pro-lon- gevity variants. Biogerontology 17(1):109–127
26. Voight BF, Peloso GM, Orho-Melander M, et al (2008) Schunkert HLifelong reduction of LDL- cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease a Mendelian Randomisation study. PLoS One 3:e2986
27. Linsel-Nitschke P, Götz A, Erdmann J, et al (2008) Schunkert HLifelong reduction of LDL
29.
-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease a Mendelian Randomisation study. PLoS One 3:e2986
28. Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, Floratos A, Sham PC, Li MJ, Wang J, Cardon LR, Whittaker JC, Sanseau P (2015) The support of human genetic evidence for approved drug indications. Nat Genet 47:856–860
30. International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret GB, Munroe PB, Rice KM, Bochud M et al. Genetic variants in novel pathways in uence blood pressure and cardiovascular disease risk. Nature 2011; 478(7367):103–109
33.
31. Morris AP, Voight BF, Teslovich TM, et al. Diabetes Genetics Replication And Meta- analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–990
34.
32. Willer CJ, Schmidt EM, Sengupta S, et al (2018) Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets. Sci Rep 8:3434
34. Braenne I, Civelek M, Vilne B, et al (2015). Prediction of causal candidate genes in coronary artery disease loci. Arterioscler Thromb Vasc Biol 35:2207–2217
36. Chen CC1, Chen LL, Hsu YT, Liu KJ, Fan CS, Huang TS (2014) The endothelin-integrin axis is involved in macrophage-induced breast cancer cell chemotactic interactions with endothelial cells. J Biol Chem 289:10029–10044.
Trương Thanh Hương: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Thị Mai Ngọc: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Thị Duyên: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;